Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.
Mirtazapine is a tetracyclic antidepressant that blocks alpha-2 adrenergic receptors, increasing the release of noradrenaline and serotonin, and blocks some serotonin and histamine receptors, which makes it sedating and appetite-stimulating. It is used for depression, especially with poor sleep or poor appetite. It is sold as Remeron and Zispin, among other names.
Mirtazapine is broken down by CYP2D6, CYP1A2 and CYP3A4. CYP2D6 poor metabolizers have somewhat higher levels of one of its mirror-image forms, rated at PharmGKB level 2A, but no guideline calls for a change. Studies have also looked at FKBP5, TPH2, CYP2B6 and others for response. There is no CPIC or DPWG guideline.
Every published finding on gene variants and Mirtazapine. Upload your DNA file to see which of these rows apply to you.
PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.
CYP2D6 CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6: Level 2A · replicated. Metabolism/PK. 5.
TPH2 rs1487278: Level 3. Efficacy: Depression. 1.
TPH2 rs10879346: Level 3. Efficacy: Major Depressive Disorder. 1.
FKBP5 rs4713916: Level 3. Efficacy: Mood Disorder. 1.
Studies of how quickly the body processes this medication.
Studies of how well it worked in people carrying a variant.
Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.
More drugs from the same category
Ludiomil (Tetracyclic Antidepressants)
Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.
Content updated September 2026.
ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.
Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026
Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com